Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

RCKT — Rocket Pharmaceuticals, Inc.

UNDERVALUED (MOS Model unreliable) · Quality 55/100

Value Score 30 days ago: 48.1 → today 48.6

RCKT - Rocket Pharmaceuticals, Inc.
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 2.48 USD
Intrinsic value: 11.95 USD
Margin of safety: Model unreliable
Implied growth (reverse DCF): -19.3% (model assumes +6.0%)
Valuation: UNDERVALUED
Value Score: 48.6
Quality: 55/100
Moat score: 0 (erosion: none)
UNDERVALUED (MOS Model unreliable) - Quality 55/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/RCKT
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

2.48

Intrinsic value

11.95

Margin of safety

Model unreliable

Implied growth (reverse DCF)

-19.3%

model assumes +6.0%

Value Score

48.6

Quality

Psychology

35.8

Discovery

10.3

price/volume attention only

Moat score

erosion: none

Value Score: top 5% of Russell 3000 · Quality: top 48%

Open the interactive Deep Dive for RCKT →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/RCKT - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is RCKT undervalued?

As of 2026-11-11, RCKT trades at 2.48 against a computed intrinsic value of 11.95 (+79.2% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Rocket Pharmaceuticals, Inc.'s Value Score?

Rocket Pharmaceuticals, Inc.'s Value Score is 48.6 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.